生物技术-自然2013-09-05 2:58 AM

Somatic Mutation, Genomic Variation, and Neurological Disease

Genetic mutations causing human disease are conventionally thought to be inherited through the germ line from one’s parents and present in all somatic (body) cells, except for most cancer mutations, which arise somatically. Increasingly, somatic mutations are being identified in diseases other than cancer, including neurodevelopmental diseases. Somatic mutations can arise during the course of prenatal brain development and cause neurological disease—even when present at low levels of mosaicism, for example—resulting in brain malformations associated with epilepsy and intellectual disability. Novel, highly sensitive technologies will allow more accurate evaluation of somatic mutations in neurodevelopmental disorders and during normal brain development.

KEYWORDS

SHARE & LIKE

COMMENTS

ABOUT THE AUTHOR

生物技术-自然

0 Following 0 Fans 0 Projects 12 Articles

SIMILAR ARTICLES

Reference genomes are required to understand the diverse roles of microorganisms in ecology, evolution, human and animal health, but most species remai

Read More

A low-error 16S ribosomal RNA amplicon sequencing method, in combination with whole-genome sequencing of >500 cultured isolates, was used to characteri

Read More

Delivery of short interfering RNAs (siRNAs) remains a key challenge in the development of RNA interference (RNAi) therapeutics. A better understanding

Read More

New high-dimensional, single-cell technologies offer unprecedented resolution in the analysis of heterogeneous tissues. However, because these technolo

Read More

In the version of this article initially published, there were two errors in the discussion of epigenetic marks on page 854. In sentence 4, paragraph 2

Read More

Genetic mutations causing human disease are conventionally thought to be inherited through the germ line from one’s parents and present in all somatic

Read More

Cell-based therapies for myelin disorders, such as multiple sclerosis and leukodystrophies, require technologies to generate functional oligodendrocyte

Read More

Transplantation of oligodendrocyte precursor cells (OPCs) is a promising potential therapeutic strategy for diseases affecting myelin. However, the der

Read More

It is currently not possible to predict which epitopes will be recognized by T cells in different individuals. This is a barrier to the thorough analys

Read More

Dysfunction of basal forebrain cholinergic neurons (BFCNs) and γ-aminobutyric acid (GABA) interneurons, derived from medial ganglionic eminence (MGE),

Read More